Inhibition of AC-II activity following chronic agonist exposure is modulated by phosphorylation

Journal of Molecular Neuroscience

Volumn 29, Issue 2, 2006, Pages 115-122

  Schallmach, Ester ^a   Steiner, Debora ^a   Vogel, Zvi ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Adenylyl cyclase; cAMP; Genistein; Opioid receptor; Phosphorylation; PKC; Raf 1 kinase; Tyrosine kinase

Indexed keywords

2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; ADENYL CYCLASE 2 ENZYME; ADENYLATE CYCLASE; GUANINE NUCLEOTIDE BINDING PROTEIN; ISOENZYME; MU OPIATE RECEPTOR AGONIST; OKADAIC ACID; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RAF PROTEIN; SORAFENIB; THYROTROPIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; DRUG EFFECT; DRUG EXPOSURE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GENETIC TRANSFECTION; NONHUMAN; PROTEIN DETERMINATION;

ADENYLATE CYCLASE; ANALGESICS, OPIOID; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENZYME INHIBITORS; HETEROTRIMERIC GTP-BINDING PROTEINS; ISOENZYMES; MORPHINE; OKADAIC ACID; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN SUBUNITS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-RAF; RECEPTORS, OPIOID, MU; RECEPTORS, THYROTROPIN;

EID: 33748459610     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1385/JMN:29:2:115     Document Type: Article

References (30)

1. βγ. J. Biol. Chem. 271, 21,309-21,315.
2. Avidor-Reiss T., Nevo I., Saya D., Bayewitch M., and Vogel Z. (1997) Opiate-induced adenylyl cyclase superactivation is isozyme specific. J. Biol. Chem. 272, 5040-5047.
3. β subunits. J. Biol. Chem. 273, 2273-2276.
4. Bayewitch M., Avidor-Reiss T., Levy R., Pfeuffer T., Nevo I., Simonds W. F., and Vogel Z. (1998b) Inhibition of adenylyl cyclase isoforms V and VI by various Gbetagamma subunits. FASEB J. 12, 1019-1025.
5. Bayewitch M., Nevo I., Avidor-Reiss T., Levy R., Simonds W. F., and Vogel Z. (2000) Alterations in detergent solubility of heterotrimeric G proteins after chronic activation of G(i/o)-coupled receptors: changes in detergent solubility are in correlation with onset of adenylyl cyclase superactivation. Mol. Pharmacol. 57, 820-825.
6. Chakrabarti S., Rivera M., Yan S. Z., Tang W. J., and Gintzler A. R. (1998a) Chronic morphine augments G(beta)(gamma)/Gs(alpha) stimulation of adenylyl cyclase: relevance to opioid tolerance. Mol. Pharmacol. 54, 655-662.
7. Chakrabarti S., Wang L., Tang W. J., and Gintzler A. R. (1998b) Chronic morphine augments adenylyl cyclase phosphorylation: relevance to altered signaling during tolerance/dependence. Mol. Pharmacol. 54, 949-953.
8. Jacobowitz O. and Iyengar R. (1994) Phorbol ester-induced stimulation and phosphorylation of adenylyl cyclase 2. Proc. Natl. Acad. Sci. U.S.A. 91, 10,630-10,634.
9. Kawabe J., Iwami G., Ebina T., Ohno S., Katada T., Ueda Y., et al. (1994) Differential activation of adenylyl cyclase by protein kinase C isoenzymes. J. Biol. Chem. 269, 16,554-16,558.
10. Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
11. Lou L. G. and Pei G. (1997) Modulation of protein kinase C and cAMP-dependent protein kinase by delta-opioid. Biochem. Biophys. Res. Commun. 236, 626-629.
12. Mollner S., Beck K., and Pfeuffer T. (1995) Acylation of adenylyl cyclase catalyst is important for enzymic activity. FEBS Lett. 371, 241-244.
13. Nasman J., Kukkonen J. P., Holmqvist T., and Akerman K. E. (2002) Different roles for Gi and Go proteins in modulation of adenylyl cyclase type-2 activity. J. Neurochem. 83, 1252-1261.
14. Nevo I., Avidor-Reiss T., Levy R., Bayewitch M., Heldman E., and Vogel Z. (1998) Regulation of adenylyl cyclase isozymes upon acute and chronic activation of inhibitory receptors. Mol. Pharmacol. 54, 419-426.
15. Schallmach E., Steiner D., and Vogel Z. (2006) Adenylyl cyclase type II activity is regulated by two different mechanisms: implications for acute and chronic opioid exposure. Neuropharmacology. Mar 14; [Epub ahead of print]
16. Simonds W. F. (1999) G protein regulation of adenylate cyclase. Trends Pharmacol. Sci. 20, 66-73.
17. Slupsky J. R., Quitterer U., Weber C. K., Gierschik P., Lohse M. J., and Rapp U. R. (1999) Binding of Gbetagamma subunits to cRaf1 downregulates G-protein-coupled receptor signalling. Curr. Biol. 9, 971-974.
18. Steiner D., Avidor-Reiss T., Schallmach E., Saya D., and Vogel Z. (2005) Inhibition and superactivation of the calcium-stimulated isoforms of adenylyl cyclase: role of gbetagamma dimers. J. Mol. Neurosci. 27, 195-204.
19. Sunahara R. K. and Taussig R. (2002) Isoforms of mammalian adenylyl cyclase: multiplicities of signaling. Mol. Interv. 2, 168-184.
20. Sunahara R. K., Dessauer C. W., and Gilman A. G. (1996) Complexity and diversity of mammalian adenylyl cyclases. Annu. Rev. Pharmacol. Toxicol. 36, 461-480.
21. Tan C. M., Kelvin D. J., Litchfield D. W., Ferguson S. S., and Feldman R. D. (2001) Tyrosine kinase-mediated serine phosphorylation of adenylyl cyclase. Biochemistry 40, 1702-1709.
22. Tsu R. C. and Wong Y. H. (1996) Gi-mediated stimulation of type II adenylyl cyclase is augmented by Gqcoupled receptor activation and phorbol ester treatment. J. Neurosci. 16, 1317-1323.
23. Varga E. V., Rubenzik M., Grife V., Sugiyama M., Stropova D., Roeske W. R., and Yamamura H. I. (2002) Involvement of Raf-1 in chronic delta-opioid receptor agonist-mediated adenylyl cyclase superactivation. Eur. J. Pharmacol. 451, 101-102.
24. Varga E. V., Rubenzik M. K., Stropova D., Sugiyama M., Grife V., Hruby V. J., et al. (2003) Converging protein kinase pathways mediate adenylyl cyclase superactivation upon chronic delta-opioid agonist treatment. J. Pharmacol. Exp. Ther. 306, 109-115.
25. Varga E. V., Stropova D., Rubenzik M., Waite S., Roeske W. R., and Yamamura H. I. (1999) Phosphorylation of adenylyl cyclase VI upon chronic delta-opioid receptor stimulation. Eur. J. Pharmacol. 364, R1-3.
26. Vogel Z., Barg J., Levy R., Saya D., Heldman E., and Mechoulam R. (1993) Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J. Neurochem. 61, 352-355.
27. Watts V. J. (2002) Molecular mechanisms for heterologous sensitization of adenylate cyclase. J. Pharmacol. Exp. Ther. 302, 1-7.
28. Watts V. J. and Neve K. A. (2005) Sensitization of adenylate cyclase by Galpha i/o-coupled receptors. Pharmacol. Ther. 106, 405-421.
29. Yoshimura M. and Cooper D. M. (1993) Type-specific stimulation of adenylylcyclase by protein kinase C. J. Biol. Chem. 268, 4604-4607.
30. Zimmermann G. and Taussig R. (1996) Protein kinase C alters the responsiveness of adenylyl cyclases to G protein alpha and betagamma subunits. J. Biol. Chem. 271, 27,161-27,166.